Novo Nordisk (Ozempic)
Acquired
Navigating the Pharmaceutical Value Chain
This chapter explores the intricate pharmaceutical value chain in the U.S., detailing the roles of key stakeholders such as manufacturers, distributors, pharmacies, and Pharmacy Benefit Managers (PBMs). It highlights how the presence of multiple intermediaries complicates drug pricing and accessibility for consumers. The chapter also examines the influence of mergers and the competitive landscape in the insulin market, reflecting on historical developments and strategic decisions in the pharmaceutical industry.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
